Kengelbach-Weigand A, Thielen C, Bäuerle T, Götzl R, Gerber T, Körner C, Beier J, Horch RE, Boos A (2021)
Publication Type: Journal article
Publication year: 2021
Book Volume: 6
Article Number: 49
Journal Issue: 1
DOI: 10.1038/s41536-021-00158-8
Tissue engineering principles allow the generation of functional tissues for biomedical applications. Reconstruction of large-scale bone defects with tissue-engineered bone has still not entered the clinical routine. In the present study, a bone substitute in combination with mesenchymal stem cells (MSC) and endothelial progenitor cells (EPC) with or without growth factors BMP-2 and VEGF-A was prevascularized by an arteriovenous (AV) loop and transplanted into a critical-size tibia defect in the sheep model. With 3D imaging and immunohistochemistry, we could show that this approach is a feasible and simple alternative to the current clinical therapeutic option. This study serves as proof of concept for using large-scale transplantable, vascularized, and customizable bone, generated in a living organism for the reconstruction of load-bearing bone defects, individually tailored to the patient’s needs. With this approach in personalized medicine for the reconstruction of critical-size bone defects, regeneration of parts of the human body will become possible in the near future.
APA:
Kengelbach-Weigand, A., Thielen, C., Bäuerle, T., Götzl, R., Gerber, T., Körner, C.,... Boos, A. (2021). Personalized medicine for reconstruction of critical-size bone defects – a translational approach with customizable vascularized bone tissue. npj Regenerative Medicine, 6(1). https://doi.org/10.1038/s41536-021-00158-8
MLA:
Kengelbach-Weigand, Annika, et al. "Personalized medicine for reconstruction of critical-size bone defects – a translational approach with customizable vascularized bone tissue." npj Regenerative Medicine 6.1 (2021).
BibTeX: Download